Publications, Posters, <br> and Other Information
Publications, Posters,
and Other Information
Filtered (9)
Filters
Areas of Interest
Techniques
Document Type
Date
Show (9)
Cancel

Publications and Posters

How can MSI enhance our understanding of ASO distribution?
January 1, 2025  •  van der Vloet, L., Hilaire, P. B. S., Bouillod, C., Isin, E. M., Heeren, R. M. A., & Vandenbosch, M. (2025).   In Drug Discovery Today ...
Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson’s disease
September 18, 2024  •  Minnella, A., McCusker, K. P., Amagata, A., Trias, B., Weetall, M., Latham, J. C., O’Neill, S., Wyse, R. K., Klein, M. B., & Trimmer, J. K. (2024). In H. Nakano (Ed.), PLOS ONE (Vol. 19, Issue 9, p. e0309893). Public Library of Science (PLoS). • Drug study incorporating MALDI-IHC, Pharma
Multiplex and multiomic MS imaging of drugs, metabolites, and immunolabeled pathogenic protein markers within a single tissue section
June 2, 2024  •  ASMS 2024 • Prem Shankar; Reina N Paez; David Beaver; Bandana Bera; Brendan Prideaux
Combining Drug and Targeted Protein Imaging to Uncover Molecular Changes Associated with Cancer Treatment
June 2, 2024  •  ASMS 2024 • Erin H. Seeley, Catherine A. Kita, Gargey Yagnik, Kenneth J. Rothschild, Mark J. Lim, Rahul A. Sheth
Multimodal Mass Spectrometry Imaging of an Osteosarcoma Multicellular Tumour Spheroid Model to Investigate Drug-Induced Response
May 29, 2024  •  Pearce, S.M.; Cross, N.A.; Smith, D.P.; Clench, M.R.; Flint, L.E.; Hamm, G.; Goodwin, R.; Langridge, J.I.; Claude, E.; Cole, L.M. Metabolites 2024, 14, 315. • Drug study, Multiomic, Multimodal, Tumor Spheroids
Real-time glioblastoma tumor microenvironment assessment by SpiderMass for improved patient management
April 16, 2024  •  Zirem, Y., Ledoux, L., Roussel, L., Maurage, C. A., Tirilly, P., Le Rhun, É., Meresse, B., Yagnik, G., Lim, M. J., Rothschild, K. J., Duhamel, M., Salzet, M., & Fournier, I. (2024). In Cell Reports Medicine (Vol. 5, Issue 4, p. 101482). Elsevier BV. • MALDI-IHC was orthogonal verification tech
Abstract 7088: MALDI-IHC high-plex protein biomarker imaging for fast, non-iterative identification of lung carcinoma subtypes
March 15, 2024  •  Kita, C. A., Schwamborn, K., Yagnik, G., Rothschild, K. J., & Lim, M. J. (2024). In Cancer Research (Vol. 84, Issue 6_Supplement, pp. 7088–7088). American Association for Cancer Research (AACR). • Clinical Translation, Published Abstract
Advancing rare cancer research by MALDI mass spectrometry imaging: Applications, challenges, and future perspectives in sarcoma
February 25, 2024  •  Stillger, M. N., Li, M. J., Hönscheid, P., von Neubeck, C., & Föll, M. C. (2024). In PROTEOMICS (Vol. 24, Issues 12–13). Wiley. • Multiomic and Multimodal techniques
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations
December 23, 2023  •  Piga, I., Magni, F., & Smith, A. (2024). In FEBS Letters (Vol. 598, Issue 6, pp. 621–634). Wiley. • Clinical Translation, Review Article